Lars Hytting
Lars Hytting is an investor at ArthaScope, known for his insights into the pharmaceutical market. Recently, he commented on the unexpected drop in Novo Nordisk's share price, indicating that even the most skeptical analysts did not anticipate such a significant decline, highlighting the intense competition in the weight-loss drug sector.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Australia:
Investor ArthaScope’s Lars Hytting told Bloomberg that even the most sceptical analyst didn’t anticipate this big a drop.
5